Concerns about Lilly's Q3 update are overblown. Lilly's impressive growth story remains intact. The stock's valuation is attractive, factoring in anticipated growth over the next several years.

Eli Lilly has seen tremendous growth from its new GLP-1 drugs, which people have been using for weight loss. Sales growth should continue as the company increases production and looks to win ...

On the clinical trials front Lilly announced plans to start a five-year real-world evidence study involving tirzepatide, the dual GIP/GLP-1 receptor agonist in the company's Mounjaro drug for type ...

Trans horror enthusiasts, rejoice: Lilly Wachowski is working on a TV adaptation of Manhunt, Gretchen Felker-Martin’s hit 2022 horror novel about a post-apocalyptic world where testosterone ...

INDIANAPOLIS, Oct. 28, 2024 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2024 of $1.30 per share on outstanding ...

Once the music starts playing, Lily dances about in a neon pink mini dress, lace gloves, and sling-back heels. 070Shake, whose real name is Danielle Balbuena, watches on from her seat while ...

But this grandmother from Alabama kept on fighting" until he signed the bill bearing her name. "Lilly did what so many Americans before her have done: setting her sights high for herself and even ...